Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials
The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
Aim This article provides the first comprehensive meta-analysis of randomized clinical trials of medications for obesity.Method Based on stringent inclusionary criteria, a total of 108 studies were included in the final database. Outcomes are presented for comparisons of single and combination drugs to placebo and for comparisons of medications to one another.Result Overall, the medications studied produced medium effect sizes. Four drugs produced large effect sizes (ie d>0.80; amphetamine, benzphetamine, fenfluramine and sibutramine). The placebo-subtracted weight losses for single drugs vs placebo included in the meta-analysis never exceeded 4.0 kg. No drug, or class of drugs, demonstrated clear superiority as an obesity medication. Effects of methodological factors are also presented along with suggestions for future research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a meta-analysis of phentermine monotherapy clinical trials, the placebo-corrected reduction in body weight with phentermine was less than 4 kg”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [49]
In the citing paper
“The pooled analysis showed that those treated with phentermine along with diet and lifestyle lost 3.6 kg more than patients treated with diet and lifestyle alone.”
From Obesity‐Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment: A Position Paper of The Obesity Society and the American Society of Hypertension (2013) · cites this paper as [196]
Citations
Cites
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Lipsey, M. W., & Wilson, D. B. (1993) · American Psychologist · doi:10.1037/0003-066x.48.12.1181 · Cited by 2,033
Estimation of effect size from a series of independent experiments.
Hedges, L. V. (1982) · Psychological Bulletin · doi:10.1037//0033-2909.92.2.490 · Cited by 1,062
The Handbook of Research Synthesis
Hanka, R. (1994) · BMJ · doi:10.1136/bmj.309.6952.488a · Cited by 1,052
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T., Feldmann, E., Morgenstern, L. B., Wilterdink, J. L., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432501 · Cited by 611
Research works printed but not linked: 3
- Scoville BA . Review of amphetamine like drugs by the Federal Drug Administration: clinical data and value judgments. In: G Bray (ed). Obesity in perspective, DHEW publication no. (NIH) 75–708. US Government Printing Office: Washington, DC 1973.
- Shadish, WR, Haddock, CK . Combining estimates of effect size. In: H Cooper, LV Hedges (eds). The handbook of research synthesis Russell Sage: New York 1994 261–281.
- National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) . Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity: the evidence report US Government Press: Washington DC 1998.
Cited by
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedFranz, M. J., VanWormer, J. J., Crain, A. L., Boucher, J. L., Histon, T., Caplan, W., Bowman, J. D., & Pronk, N. P. (2007) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.07.017 · Cited by 1,559
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Metadata
- Authors
- Haddock, C., Poston, W., Dill, P., Foreyt, J., & Ericsson, M.
- Affiliations
- Saint Luke's Hospital (US)
- University of Missouri–Kansas City (US)
- Venue
- International Journal of Obesity
- Published
- 2002-02
- Volume
- 26
- Issue
- 2
- Pages
- 262-273
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2069004141
- Cited by
- 303
- References
- 23
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 9 · 2015: 17 · 2014: 8 · 2013: 21 · 2012: 15
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- obesity pharmacotherapy, anti-obesity drugs, weight loss, amphetamine, fenfluramine, sibutramine, benzphetamine, combination therapy, placebo effect, drug efficacy comparison, methodological factors
- MeSH terms
- Amphetamines, Benzphetamine, Cyclobutanes, Fenfluramine, Humans, Obesity, Randomized Controlled Trials as Topic, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. https://app.cochat.ai/papers/10.1038/sj.ijo.0801889
- The paper
- Haddock, C., Poston, W., Dill, P., Foreyt, J., & Ericsson, M. (2002). Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. International Journal of Obesity. https://doi.org/10.1038/sj.ijo.0801889
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.